Tag: insider sales

The SEC Plans to Further Regulate 10b5-1 Plans

The SEC Plans to Further Regulate 10b5-1 Plans

This is a win for investors and could potentially be a "Big" win if new 10b5-1 regulations are tough. Too frequently CEOs and named executives skirt around insider trading rules by way of 10b5-1 plans - especially the modification of existing 10b5-1 plans. Last year we called out Moderna (MRNA) CEO St├ęphane Bancel for this … Continue reading The SEC Plans to Further Regulate 10b5-1 Plans

Moderna Insider Sales Raise Corporate Governance Flags

Moderna Insider Sales Raise Corporate Governance Flags

Over the past year Moderna (ticker: MRNA) insiders have sold equity worth approximately $292 million as of July 27th 2020. This includes CEO St├ęphane Bancel whom has sold equity worth approximately $33 million and Chief Medical Officer Tal Zaks whom has sold equity worth approximately $55 million over the same period. MRNA insider sales. Click … Continue reading Moderna Insider Sales Raise Corporate Governance Flags

Insider Selling & Share Repurchases – A Corporate Governance Problem

Insider Selling & Share Repurchases – A Corporate Governance Problem

It is a corporate governance problem when insiders sell shares in the face of share repurchase programs. Take the example of Copart (ticker: CPRT). CPRT insiders have not purchased any shares over the past several years, yet they have done plenty of selling. Further, CPRT share repurchases helped support the stock while insiders sold (see … Continue reading Insider Selling & Share Repurchases – A Corporate Governance Problem